Updates are available Correction dated 2021-03-02
Click to view Correction: https://doi.org/10.1038/s41586-021-03331-7
-
Authors
Ben-Sasson, Ariel J.
Watson, Joseph L. https://orcid.org/0000-0001-5492-0249
Sheffler, William
Johnson, Matthew Camp
Bittleston, Alice https://orcid.org/0000-0002-1374-0222
Somasundaram, Logeshwaran
Decarreau, Justin
Jiao, Fang https://orcid.org/0000-0001-5087-6228
Chen, Jiajun
Mela, Ioanna https://orcid.org/0000-0002-2914-9971
Drabek, Andrew A.
Jarrett, Sanchez M.
Blacklow, Stephen C. https://orcid.org/0000-0002-6904-1981
Kaminski, Clemens F. https://orcid.org/0000-0002-5194-0962
Hura, Greg L.
De Yoreo, James J. https://orcid.org/0000-0002-9541-733X
Kollman, Justin M. https://orcid.org/0000-0002-0350-5827
Ruohola-Baker, Hannele https://orcid.org/0000-0002-5588-4531
Derivery, Emmanuel https://orcid.org/0000-0003-3927-5944
Baker, David https://orcid.org/0000-0001-7896-6217
- License Information
-
More Information
Article History
Received: 19 April 2019
Accepted: 6 November 2020
First Online: 6 January 2021
Change Date: 2 March 2021
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41586-021-03331-7
Competing interests
: S.C.B. receives funding for unrelated projects from the Novartis Institutes for Biomedical Research and from Erasca. He is on the Scientific Advisory Board for Erasca, and is a consultant on unrelated projects for IFM and Ayala Therapeutics.
